Antibiotics and BCG.
作者信息
Messing Edward M
机构信息
University of Rochester Medical Center, Rochester, NY, USA.
出版信息
Bladder Cancer. 2022 Mar 11;8(1):97-99. doi: 10.3233/BLC-229000. eCollection 2022.
Abstract
摘要
相似文献
1
Antibiotics and BCG.抗生素与卡介苗
Bladder Cancer. 2022 Mar 11;8(1):97-99. doi: 10.3233/BLC-229000. eCollection 2022.
2
Antibiotic therapy impact on intravesical BCG therapy efficacy for high-risk localized bladder cancer treatment.抗生素治疗对高危局限性膀胱癌治疗中膀胱内卡介苗治疗疗效的影响。
Front Oncol. 2024 Mar 8;13:1240378. doi: 10.3389/fonc.2023.1240378. eCollection 2023.
3
Association Between Antibiotic Treatment and the Efficacy of Intravesical BCG Therapy in Patients With High-Risk Non-Muscle Invasive Bladder Cancer.高危非肌层浸润性膀胱癌患者抗生素治疗与膀胱内卡介苗治疗疗效之间的关联
Front Oncol. 2021 Apr 2;11:570077. doi: 10.3389/fonc.2021.570077. eCollection 2021.
4
Treating BCG-induced disease in children.治疗儿童卡介苗诱导的疾病。
Cochrane Database Syst Rev. 2013 Jan 31;2013(1):CD008300. doi: 10.1002/14651858.CD008300.pub2.
5
Outpatient urological procedures in antibiotic-naive patients with bladder cancer with asymptomatic bacteriuria.膀胱癌伴无症状菌尿的抗生素初治患者的门诊泌尿科操作。
BJU Int. 2012 Dec;110(11 Pt B):E658-60. doi: 10.1111/j.1464-410X.2012.11405.x. Epub 2012 Aug 9.
6
Sensitivity of BCG to modern antibiotics.卡介苗对现代抗生素的敏感性。
Eur Urol. 2000;37 Suppl 1:21-5. doi: 10.1159/000052378.
7
Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.牛分枝杆菌卡介苗疫苗株对抗结核抗生素的敏感性。
Antimicrob Agents Chemother. 2009 Jan;53(1):316-8. doi: 10.1128/AAC.01302-08. Epub 2008 Oct 27.
8
Intravesical bacille Calmette-Guérin eradicates bacteriuria in antibiotic-naïve bladder cancer patients.膀胱内卡介苗根除抗生素初治膀胱癌患者的菌尿症。
Eur Urol. 2013 May;63(5):832-5. doi: 10.1016/j.eururo.2012.08.013. Epub 2012 Aug 20.
9
Systemic BCG-Osis as a Rare Side Effect of Intravesical BCG Treatment for Superficial Bladder Cancer.系统性卡介苗病作为浅表性膀胱癌膀胱内卡介苗治疗的罕见副作用
Case Rep Urol. 2013;2013:821526. doi: 10.1155/2013/821526. Epub 2013 Jun 17.
10
Comparison of intravesical adjuvant therapy in bladder cancer with two different maintenance regimens of mitomycin and BCG.膀胱癌膀胱内辅助治疗中丝裂霉素和卡介苗两种不同维持方案的比较。
Urologia. 2022 Feb;89(1):53-57. doi: 10.1177/03915603211050783. Epub 2021 Oct 20.
本文引用的文献
1
Association Between Antibiotic Treatment and the Efficacy of Intravesical BCG Therapy in Patients With High-Risk Non-Muscle Invasive Bladder Cancer.高危非肌层浸润性膀胱癌患者抗生素治疗与膀胱内卡介苗治疗疗效之间的关联
Front Oncol. 2021 Apr 2;11:570077. doi: 10.3389/fonc.2021.570077. eCollection 2021.
2
Microbiome analyses of blood and tissues suggest cancer diagnostic approach.血液和组织的微生物组分析提示癌症诊断方法。
Nature. 2020 Mar;579(7800):567-574. doi: 10.1038/s41586-020-2095-1. Epub 2020 Mar 11.
3
Does asymptomatic bacteriuria affect the response to intravesical bacillus Calmette-Guérin?无症状菌尿是否会影响对膀胱内卡介苗的反应？
Int J Urol. 2020 Jan;27(1):72-74. doi: 10.1111/iju.14139. Epub 2019 Oct 29.
4
Male Bladder Microbiome Relates to Lower Urinary Tract Symptoms.男性膀胱微生物群与下尿路症状相关。
Eur Urol Focus. 2020 Mar 15;6(2):376-382. doi: 10.1016/j.euf.2018.08.001. Epub 2018 Aug 22.
5
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors.肠道微生物组影响基于 PD-1 的免疫疗法对上皮性肿瘤的疗效。
Science. 2018 Jan 5;359(6371):91-97. doi: 10.1126/science.aan3706. Epub 2017 Nov 2.
6
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine.肿瘤内细菌在介导肿瘤对化疗药物吉西他滨耐药中的潜在作用。
Science. 2017 Sep 15;357(6356):1156-1160. doi: 10.1126/science.aah5043.
7
Colonization with enterotoxigenic Bacteroides fragilis is associated with early-stage colorectal neoplasia.产肠毒素脆弱拟杆菌的定植与早期结直肠肿瘤形成有关。
PLoS One. 2017 Feb 2;12(2):e0171602. doi: 10.1371/journal.pone.0171602. eCollection 2017.
8
Antiandrogen Therapy with Hydroxyflutamide or Androgen Receptor Degradation Enhancer ASC-J9 Enhances BCG Efficacy to Better Suppress Bladder Cancer Progression.使用羟基氟他胺或雄激素受体降解增强剂ASC-J9进行抗雄激素治疗可增强卡介苗的疗效，从而更好地抑制膀胱癌进展。
Mol Cancer Ther. 2015 Nov;14(11):2586-94. doi: 10.1158/1535-7163.MCT-14-1055-T. Epub 2015 Aug 11.
9
Expert consensus document: Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer.专家共识文件：关于膀胱癌卡介苗膀胱内免疫治疗应用的最佳实践管理的共识声明。
Nat Rev Urol. 2015 Apr;12(4):225-35. doi: 10.1038/nrurol.2015.58. Epub 2015 Mar 24.
10
The mechanism of action of BCG therapy for bladder cancer--a current perspective.BCG 疗法治疗膀胱癌的作用机制——当前的观点。
Nat Rev Urol. 2014 Mar;11(3):153-62. doi: 10.1038/nrurol.2014.15. Epub 2014 Feb 4.
Zotero 插件